Publication | Closed Access

Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment

First-line TherapyUrologyOncologyMedicineCancer ManagementWeekly Nab-paclitaxelCancer TreatmentPharmacologyRadiation OncologyLung CancerMolecular OncologyRenal Impairment